Literature DB >> 15850833

Diverse effects of the Notch ligands Jagged1 and Delta1 on the growth and differentiation of primary acute myeloblastic leukemia cells.

Shuji Tohda1, Hanae Kogoshi, Naomi Murakami, Seiji Sakano, Nobuo Nara.   

Abstract

OBJECTIVE: Notch signaling plays a role in regulating the self-renewal and differentiation of hematopoietic progenitors. Since acute myeloblastic leukemia (AML) originates from dysregulated hematopoietic progenitors, the Notch system may be involved in the abnormal growth. We previously reported that AML cells express Notch proteins. In this study, we examined the effects of recombinant human Notch ligand proteins, Jagged1 and Delta1, on the growth and differentiation of primary AML cells.
MATERIALS AND METHODS: AML cells separated from blood from 12 patients were cultured in wells coated with Jagged1, Delta1, or control IgG. The short-term growth was evaluated using a colorimetric assay. The self-renewal capacity was evaluated by the clonogenic cells recovered, which were obtained via a colony assay involving cells cultured with the ligands or control IgG. Differentiation was evaluated by the morphology of the cultured cells and flow cytometric analysis.
RESULTS: The ligand stimulation caused three types of response in the short-term growth of the primary AML cells, namely, promotion, suppression, or no significant effect. The self-renewal capacity was suppressed or not significantly affected by the ligands, even in cells showing short-term growth promotion. The ligand stimulation altered blast cells into macrophage-like cells from their morphology and increased the expression of differentiation markers such as CD13 or CD14 in some samples.
CONCLUSIONS: The Notch ligands had diverse effects on the short-term growth of primary AML cells. The ligands did not promote the self-renewal capacity of any of the cells examined and instead tended to induce differentiation under the conditions used.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15850833     DOI: 10.1016/j.exphem.2005.01.010

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  18 in total

1.  Combined inhibition of Notch and FLT3 produces synergistic cytotoxic effects in FLT3/ITD+ acute myeloid leukemia.

Authors:  Dan Li; Tongjuan Li; Zhen Shang; Lei Zhao; Qian Xu; Jiaqi Tan; Yun Qin; Yuanyuan Zhang; Yang Cao; Na Wang; Liang Huang; Xiaojian Zhu; Kuangguo Zhou; Liting Chen; Chunrui Li; Ting Xie; Yi Yang; Jue Wang; Jianfeng Zhou
Journal:  Signal Transduct Target Ther       Date:  2020-03-13

2.  Notch signaling maintains proliferation and survival of the HL60 human promyelocytic leukemia cell line and promotes the phosphorylation of the Rb protein.

Authors:  Guo-Hui Li; Yu-Zhen Fan; Xiao-Wei Liu; Bing-Fang Zhang; Dan-Dan Yin; Fei He; Si-Yong Huang; Zhi-Jie Kang; Heng Xu; Qiang Liu; Yan-Lan Wu; Xiao-Li Niu; Li Zhang; Li Liu; Miao-Wang Hao; Hua Han; Ying-Min Liang
Journal:  Mol Cell Biochem       Date:  2010-02-16       Impact factor: 3.396

Review 3.  Mechanisms and clinical prospects of Notch inhibitors in the therapy of hematological malignancies.

Authors:  Yulia Nefedova; Dmitry Gabrilovich
Journal:  Drug Resist Updat       Date:  2008-10-31       Impact factor: 18.500

4.  Soluble forms of the Notch ligands Delta1 and Jagged1 promote in vivo tumorigenicity in NIH3T3 fibroblasts with distinct phenotypes.

Authors:  Sumithra Urs; Alice Roudabush; Christine F O'Neill; Ilka Pinz; Igor Prudovsky; Doreen Kacer; Yuefang Tang; Lucy Liaw; Deena Small
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

Review 5.  Notch signaling in pediatric malignancies.

Authors:  Patrick A Zweidler-McKay
Journal:  Curr Oncol Rep       Date:  2008-11       Impact factor: 5.075

6.  Notch activation is associated with tetraploidy and enhanced chromosomal instability in meningiomas.

Authors:  Gilson S Baia; Stefano Stifani; Edna T Kimura; Michael W McDermott; Russell O Pieper; Anita Lal
Journal:  Neoplasia       Date:  2008-06       Impact factor: 5.715

Review 7.  Notch signaling: switching an oncogene to a tumor suppressor.

Authors:  Camille Lobry; Philmo Oh; Marc R Mansour; A Thomas Look; Iannis Aifantis
Journal:  Blood       Date:  2014-03-07       Impact factor: 22.113

8.  Future perspectives: therapeutic targeting of notch signalling may become a strategy in patients receiving stem cell transplantation for hematologic malignancies.

Authors:  Elisabeth Ersvaer; Kimberley J Hatfield; Håkon Reikvam; Oystein Bruserud
Journal:  Bone Marrow Res       Date:  2010-10-04

9.  Flow cytometric analysis of Notch1 and Jagged1 expression in normal blood cells and leukemia cells.

Authors:  Eriko Kanamori; Mai Itoh; Naoko Tojo; Takatoshi Koyama; Nobuo Nara; Shuji Tohda
Journal:  Exp Ther Med       Date:  2012-07-04       Impact factor: 2.447

10.  Notch activation inhibits AML growth and survival: a potential therapeutic approach.

Authors:  Sankaranarayanan Kannan; Robert M Sutphin; Mandy G Hall; Leonard S Golfman; Wendy Fang; Riitta M Nolo; Lauren J Akers; Richard A Hammitt; John S McMurray; Steven M Kornblau; Ari M Melnick; Maria E Figueroa; Patrick A Zweidler-McKay
Journal:  J Exp Med       Date:  2013-01-28       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.